Vir Biotechnology (VIR) Treasury Shares (2018 - 2025)

Vir Biotechnology's Treasury Shares history runs 8 years deep, the most recent figure standing at $5.7 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 14.23% year-over-year to $5.7 million; the TTM figure through Dec 2025 stood at $5.7 million (up 14.23% YoY), while the FY2025 annual figure was $5.7 million, up 14.23% from the prior year.
• Treasury Shares came in at $5.7 million for Q4 2025 at Vir Biotechnology, up from $5.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.7 million in Q4 2025 to a low of $36298.0 in Q1 2021.
• A 5-year average of $2.9 million and a median of $2.7 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 97.51% in 2021 and soared 7452.44% in 2022, its largest moves.
• Vir Biotechnology's Treasury Shares stood at $1.3 million in 2021, then surged by 109.84% to $2.7 million in 2022, then soared by 80.11% to $4.8 million in 2023, then gained by 3.67% to $5.0 million in 2024, then gained by 14.23% to $5.7 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $5.7 million, $5.0 million, and $4.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison